Results 271 to 280 of about 1,103,970 (339)

Costs of the chain of treatment procedures in acute myocardial infarction in Brazilian reference and specialized hospitals

, 2012
Rosa María Marques, Áquilas Mendes, Marcel Guedes Leite, Estela Capelas Barbosa   +3 more
openalex   +1 more source

Cardiovascular Risk of Romosozumab vs. Teriparatide: A Cohort Study Using Japan’s National Claims Database

Clinical Pharmacology &Therapeutics, EarlyView.
Disproportionality analyses suggested a cardiovascular risk signal for romosozumab, while statistically significant associations were not found in the real‐world database studies. Therefore, a larger comparative study was necessary to examine this signal.
Hotaka Maruyama, Eiko Iwasa, Shinya Watanabe, Tomoaki Hasegawa, Kazuhiro Kajiyama, Taihei Tanaka   +5 more
wiley   +1 more source

Managing Acute Myocardial Infarction in Shock and Anemia. [PDF]

JACC Case Rep
Madanchi M, Belley-Côté EP, Bansal A, Maiorano S, Tsang MB.   +4 more
europepmc   +1 more source

Acute electrocardiographic changes associated with successful coronary thrombolysis in acute myocardial infarction.

, 1987
Hiroshi Sato, Kazuhisa Kodama, Tohru Masuyama, Shinsuke Nanto, Kazuo Komamura, Michitoshi Inoue   +5 more
openalex   +2 more sources

Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug‐Eluting Stent Implantation

Clinical Pharmacology &Therapeutics, EarlyView.
From the nationwide multicenter consortium, 8,163 patients undergoing drug‐eluting stent implantation were classified according to the presence of the CYP2C19 loss‐of‐function (LoF) allele: rapid or normal metabolizers (RMs/NMs) vs. intermediate or poor metabolizers (IMs/PMs), and clinical risk was stratified using the CHADS‐P2A2RC and TRS 2°P scores ...
Hyun Woong Park, Jae‐Hwan Lee, Jin‐Ok Jeong, Diana A. Gorog, Udaya S. Tantry, Byeong‐Keuk Kim, Hyung Joon Joo, Kiyuk Chang, Jin‐Yong Hwang, Young Bin Song, Sung Gyun Ahn, Jung‐Won Suh, Woong Gil Choi, Jung Rae Cho, Jeehoon Kang, Sang Yeub Lee, Hyo‐Soo Kim, Moo Hyun Kim, Do‐Sun Lim, Eun‐Seok Shin, Paul A. Gurbel, Young‐Hoon Jeong, on behalf of the PTRG‐DES Consortium Investigators   +22 more
wiley   +1 more source

Drug-Coated Balloon-Based Intervention for De Novo Acute Myocardial Infarction. [PDF]

Yonsei Med J
Her AY, Kim S, Kang DO, Sohn CB, Kim YH, Kim B, Shin ES.   +6 more
europepmc   +1 more source

Untargeted Metabolomics Identifies N‐Lactoyl‐Amino Acids as Dose‐Responsive Plasma Biomarkers of Metformin Adherence in Type 2 Diabetes

Clinical Pharmacology &Therapeutics, EarlyView.
Metformin is the most widely prescribed antidiabetic drug, yet adherence remains difficult to objectively assess. Using untargeted metabolomics and lipidomics, we analyzed plasma from 637 patients with type 2 diabetes (T2D) with confirmed metformin use and 143 nondiabetic controls, annotating 614 metabolites.
Tomas Cajka, Jiri Hricko, Lucie Rudl Kulhava, Michaela Paucova, Michaela Novakova, Veronika Hola, Stanislava Rakusanova, Oliver Fiehn, Vojtech Skop, Ivana Lankova, Iva Miskova, Terezie Pelikanova, Martin Haluzik   +12 more
wiley   +1 more source

Daylight Savings Time and Acute Myocardial Infarction.

JAMA Netw Open
Rymer JA, Li S, Chiswell K, Kansal A, Nanna MG, Gutierrez JA, Feldman DN, Rao SV, Swaminathan RV.   +8 more
europepmc   +1 more source

Risk factors for mechanical complications in very elderly patients with acute myocardial infarction. [PDF]

Front Med (Lausanne)
Yan L, Yuan W.
europepmc   +1 more source